“Never for me the lowered banner, never the last

New Post Public Reply Private Reply Replies (2) Message Board
SporadicE Plotinus #134215
800
“Never for me the lowered banner, never the last endeavour.”
Sir Ernest Shackleton

I have stood at the gravesite of this man and pondered his adventurous life and his adherence to achieving his goals. He was a real hero.
We should emulate his goal achieving actions regarding CYDY.
It is fairly obvious that the FDA has viewed CYDY as a problem child for reasons that have been beaten to death here.
With a problem child the parent or Authority will spend extra time and effort in order to get the child back on the correct path. That is what is happening now with CYDY and the FDA. Once the informal discussions have convinced the FDA that CYDY is on a corrected course, then the hold will be lifted and further progress will be made.
We will never be privy to these informal discussions but they could very well involve prodding by the FDA to look again at LL and HIV since LL appeared to work very well in keeping HIV in check... but I doubt we'll ever know for sure.
We will be informed of discrete decisions and finished agreements which might affect share price...but we will be the last to know because CYDY is trying to become a non-problem child now. Talking out of school won't happen any more.
Watch CA's actions in the near future and ignore all the rest of the verbiage concerning CYDY.
LL is a very special covalent compound which will impact a lot of lives in a lot of ways.
If Shackleton and his two sailors could navigate by the stars and find Elephant Island in a rowboat against some very big odds, then we can wait for CA to continue his informal talks with the FDA until CYDY is not a problem any more.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 44

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 29

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 36

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 46

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 36

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 42

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 36

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Verkkokauppa.com Enhances Transparency with New Policy Update

Updated Category News Views 279

Verkkokauppa.com Enhances Transparency with New Policy Update Verkkokauppa.com Oyj recently updated its disclosure policy to strengthen its communication practices with capital markets and stakeholders. This significant update, which was approved by the company’s Board of Directors, reflects their ongoing commitment to transparency and accountability. The updated policy...

Continue Reading
Vicat's Q3 2024 Performance: Financial Insights and Future Prospects

Updated Category News Views 229

Vicat Reports Third Quarter 2024 Financial Results In the latest quarter, Vicat has demonstrated resilience with an organic sales growth of +3.3% over the first nine months of the year. This positive trend is particularly noteworthy against a backdrop of challenging market conditions. Challenges and Economic Impact Despite the overall growth, Vicat faced certain hurdles,...

Continue Reading
Hyzon's Return to Nasdaq Compliance Promises Future Growth

Updated Category News Views 150

Hyzon made headlines when it announced it had successfully regained compliance with Nasdaq's listing standards. This news wasn’t just some regulatory checkbox; it represented a significant turnaround for a company previously grappling with bid price deficiencies that had put its future at risk. Traders on the floor were immediately buzzing about what this meant for...

Continue Reading
Risks of BTMPS in Fentanyl Highlight Urgent Need for Change

Updated Category News Views 280

Worrying Surge of BTMPS in Fentanyl Supply There's been a troubling development with the discovery of an industrial chemical known as bis (2,2,6,6-tetramethyl-4-piperidyl) sebacate, or BTMPS, in illicit fentanyl across the United States. Originally used in plastics to protect against UV rays, the presence of BTMPS in fentanyl raises major health concerns. Thousands...

Continue Reading
ChannelEngine Partners with Salsify to Enhance Global Reach

Updated Category News Views 198

ChannelEngine Partners with Salsify to Enhance Global Reach ChannelEngine, an innovative marketplace integration and automation platform, has officially partnered with Salsify, a leader in Product Experience Management (PXM) and content syndication. This strategic alliance aims to assist brands in broadening their market presence, enhancing performance, and efficiently...

Continue Reading